Conference abstract
Managing the complications of Parkinson?s disease treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Parkinson?s disease is a complex disease process that affects millions of people worldwide. The current treatment of Parkinson?s disease in the United States consists of several classes of medications, each of which have multiple adverse effects. Management of Parkinson?s disease is difficult as these medications may interfere with the other disease process of patients, placing them at a higher risk for adverse events. In addition, the polypharmacy component of these complicated patients increases the risk for drug interactions. This presentation will serve to review the management of Parkinson?s disease, the motor complications associated with the medications that treat Parkinson?s disease and considerations for Parkinson?s disease management in those with complicating disease processes, such as dementia with behaviors.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “G. Blair Sarbacker”
